{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:44:31Z","timestamp":1781934271150,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["zefq-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.zefq.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T23:21:17Z","timestamp":1676848877000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Routine practice data of three cancer entities: Comparison among cancer registry and health insurance data"],"prefix":"10.1016","volume":"177","author":[{"given":"Lisa M.","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Christian Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike","family":"Basedow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Justenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.zefq.2023.01.001_b0005","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","article-title":"Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician","volume":"35","author":"Blonde","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.zefq.2023.01.001_b0010","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1097\/CEJ.0000000000000388","article-title":"Toward a comprehensive cancer registration in Germany","author":"Holleczek","year":"2017","journal-title":"Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP"},{"issue":"Suppl 1","key":"10.1016\/j.zefq.2023.01.001_b0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.zefq.2016.04.008","article-title":"The contribution of clinical cancer registries to benefit assessments: Requirements and first results","volume":"112","author":"Klinkhammer-Schalke","year":"2016","journal-title":"Z Evidenz Fortbild Qual Im Gesundheitswesen"},{"key":"10.1016\/j.zefq.2023.01.001_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.puhe.2022.02.013","article-title":"Sampling strategy, characteristics and representativeness of the InGef research database","volume":"Bd. 206","author":"Ludwig","year":"2022","journal-title":"Public Health"},{"key":"10.1016\/j.zefq.2023.01.001_b0025","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Informatik, \u201eInternationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme 10. Revision German Modification Version 2020\u201c, 2020. https:\/\/www.dimdi.de\/static\/de\/klassifikationen\/icd\/icd-10-gm\/kode-suche\/htmlgm2020\/ (zugegriffen 6. Juli 2020)."},{"key":"10.1016\/j.zefq.2023.01.001_b0030","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Informatik, \u201eOperationen- und Prozedurenschl\u00fcssel Version 2020\u201c, 2020. https:\/\/www.dimdi.de\/static\/de\/klassifikationen\/ops\/kode-suche\/opshtml2020\/ (zugegriffen 6. Juli 2020)."},{"key":"10.1016\/j.zefq.2023.01.001_b0035","unstructured":"\u201eFallpauschalen-Katalog 2020, InEK GmbH\u201c. https:\/\/www.g-drg.de\/aG-DRG-System_2020\/Fallpauschalen-Katalog\/Fallpauschalen-Katalog_2020 (zugegriffen 5. August 2022)."},{"key":"10.1016\/j.zefq.2023.01.001_b0040","unstructured":"\u201eATC-Klassifikation\u201c. https:\/\/www.dimdi.de\/dynamic\/de\/arzneimittel\/atc-klassifikation (zugegriffen 19. August 2021)."},{"key":"10.1016\/j.zefq.2023.01.001_b0045","unstructured":"C. Wittekind, TNM Klassifikation maligner Tumoren, 8. Aufl. Wiley-VCH, Weinheim, 2017. Zugegriffen: 18. August 2021. [Online]. Verf\u00fcgbar unter: https:\/\/www.wiley-vch.de\/de\/fachgebiete\/medizin-und-gesundheit\/tnm-klassifikation-maligner-tumoren-978-3-527-34280-8"},{"key":"10.1016\/j.zefq.2023.01.001_b0050","unstructured":"\u201e\u00a7 65c SGB 5 - Einzelnorm\u201c. https:\/\/www.gesetze-im-internet.de\/sgb_5\/__65c.html (zugegriffen 19. August 2021)."},{"key":"10.1016\/j.zefq.2023.01.001_b0055","unstructured":"\u201eAmtliche Ver\u00f6ffentlichungen \u2013 Bundesanzeiger\u201c. https:\/\/www.bundesanzeiger.de\/pub\/de\/amtliche-veroeffentlichung?1 (zugegriffen 18. August 2021)."},{"key":"10.1016\/j.zefq.2023.01.001_b0060","unstructured":"R. Koch-Institut, \u201eKrebs in Deutschland f\u00fcr 2017\/2018\u201c, S. 172."},{"key":"10.1016\/j.zefq.2023.01.001_b0065","unstructured":"R. Robert-Koch-Institut, \u201eKrebs in Deutschland | 2015\/2016\u201c, S. 163."},{"key":"10.1016\/j.zefq.2023.01.001_b0070","doi-asserted-by":"crossref","unstructured":"F. Hoffmann und A. Icks, \u201e[Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor]\u201c, Gesundheitswesen Bundesverb. Arzte Offentlichen Gesundheitsdienstes Ger., Bd. 74, Nr. 5, S. 291\u2013297, Mai 2012, doi: 10.1055\/s-0031-1275711.","DOI":"10.1055\/s-0031-1275711"},{"issue":"1","key":"10.1016\/j.zefq.2023.01.001_b0075","first-page":"e1","article-title":"Verschiedene Regionen, verschiedene Versichertenpopulationen? Soziodemografische und gesundheitsbezogene Unterschiede zwischen Krankenkassen","volume":"79","author":"Hoffmann","year":"2017","journal-title":"Gesundheitswesen"},{"issue":"3","key":"10.1016\/j.zefq.2023.01.001_b0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00103-012-1626-9","volume":"56","author":"Jaunzeme","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.zefq.2023.01.001_b0085","doi-asserted-by":"crossref","unstructured":"Rummel S, Hueman MT, Costantino N, Shriver CD, Ellsworth RE. \u201eTumour location within the breast: Does tumour site have prognostic ability?\u201c, 13. Juli 2015. http:\/\/ecancer.org\/en\/journal\/article\/552-tumour-location-within-the-breast-does-tumour-site-have-prognostic-ability (zugegriffen 11. August 2022).","DOI":"10.3332\/ecancer.2015.552"},{"key":"10.1016\/j.zefq.2023.01.001_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-019-0784-y","article-title":"Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data","volume":"19","author":"Oppelt","year":"2019","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"10.1016\/j.zefq.2023.01.001_b0095","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2217\/fon-2021-1417","article-title":"Real-world treatment patterns in resectable (stages I-III) non-small-cell lung cancer: a systematic literature review","volume":"18","author":"Waser","year":"2022","journal-title":"Future Oncol"},{"key":"10.1016\/j.zefq.2023.01.001_b0100","unstructured":"Liu W, Liu A, Chan J, Boldt RG, Munoz-Schuffenegger P, Louie AV. \u201eWhat is the optimal radiotherapy utilization rate for lung cancer?\u2014a systematic review\u201c, Transl. Lung Cancer Res., Bd. 0, Nr. 0, Sep. 2019, Zugegriffen: 11. August 2022. [Online]. Verf\u00fcgbar unter: https:\/\/tlcr.amegroups.com\/article\/view\/31055"},{"key":"10.1016\/j.zefq.2023.01.001_b0105","unstructured":"\u201eBreast cancer treatment statistics\u201c, Cancer Research UK, 14. Mai 2015. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/diagnosis-and-treatment (zugegriffen 14. September 2021)"},{"issue":"7","key":"10.1016\/j.zefq.2023.01.001_b0110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/jamasurg.2021.1438","article-title":"Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women","volume":"156","author":"de Boniface","year":"2021","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.zefq.2023.01.001_b0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s13224-020-01316-6","article-title":"Guidance and Standards for Breast Cancer Care in Europe","volume":"70","author":"De Wilde","year":"2020","journal-title":"J Obstet Gynecol India"},{"key":"10.1016\/j.zefq.2023.01.001_b0120","unstructured":"\u201eS3-Leitlinie Mammakarzinom\u201c, S. 467, 2021."},{"issue":"1","key":"10.1016\/j.zefq.2023.01.001_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/pcan.2016.43","article-title":"Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study","volume":"20","author":"Hager","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.zefq.2023.01.001_b0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-10-152","article-title":"Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)","volume":"10","author":"Schymura","year":"2010","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.zefq.2023.01.001_b0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4331\/wjbc.v6.i3.231","article-title":"Current medical treatment of estrogen receptor-positive breast cancer","volume":"6","author":"Lumachi","year":"2015","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.zefq.2023.01.001_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101652","article-title":"Validity of state cancer registry treatment information for adolescent and young adult women","volume":"64","author":"Anderson","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.zefq.2023.01.001_b0145","unstructured":"\u201eS3-Leitlinie Lungenkarzinom\u201c, S. 417, 2018."},{"issue":"2","key":"10.1016\/j.zefq.2023.01.001_b0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healthpol.2016.01.007","article-title":"Status and perspectives of claims data analyses in Germany-A systematic review","volume":"120","author":"Kreis","year":"2016","journal-title":"Health Policy Amst Neth"}],"container-title":["Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S186592172300003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S186592172300003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:02:30Z","timestamp":1761724950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S186592172300003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":30,"alternative-id":["S186592172300003X"],"URL":"https:\/\/doi.org\/10.1016\/j.zefq.2023.01.001","relation":{},"ISSN":["1865-9217"],"issn-type":[{"value":"1865-9217","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine practice data of three cancer entities: Comparison among cancer registry and health insurance data","name":"articletitle","label":"Article Title"},{"value":"Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.zefq.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}